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Abstract: Neurotrophic natural products hold potential as privileged 
structures for the development of therapeutic agents against 
neurodegeneration. However, only few studies have been conducted 
in order to investigate a common pharmacophoric motif and the 
structure-activity relationship. Here, an investigation of structurally 
more simple analogs of neurotrophic sesquiterpenes of the illicium 
family is presented. A concise synthetic route enables the preparation 
of the carbon framework of ()-Merrilactone A and ()-Anislactone A/B 
in gram-scale. Thereby providing access to a series of structural 
analogs by modification of the core structure, including variation of 
oxidation levels and alteration of functional groups. In total, 15 
derivatives of the natural products have been synthesized and tested 
for their neurite outgrowth activity. Our studies indicate that the 
promising biological activity can be retained by structurally more 
simple natural product analogs, which are accessible by a 
straightforward synthetic route. 
Introduction 
The awe-inspiring structural diversity of natural products has 
always motivated organic chemists to investigate and develop 
new synthetic routes, methods and applications. Significant 
discoveries have been made by studying the chemical structure 
of these compound and their properties. In particular, the 
investigation of promising biological activities has resulted in an  
Figure 1. a Neurotrophic sesquiterpene natural products with their core 
structure (marked in grey). b Natural product analogs and retrosynthesis.  
array of applications of natural products and their analogs as 
pharmaceuticals. Therefore, natural products are often used as a 
starting point for drug discovery, in which lead compounds 
undergo extensive optimization and structural variation. However, 
the complexity of natural products can often only be constructed 
via lengthy synthetic routes which may hamper drug discovery. 
One approach to circumvent this issue is to reduce the complexity 
of the natural products, while retaining the desired biological 
activity. Such strategies have been recently summarized by 
Gademann and co-workers who described the promising role of 
natural product based fragments in drug discovery. They 
highlighted examples where the structural complexity of natural 
products was reduced successfully.[1] Structurally more simple 
analogues, accessible via shorter synthetic routes, can greatly 
improve chemical tractability and can therefore overcome the 
limitations of lengthy chemical syntheses. 
Since the discovery of several neurotrophic natural products 
which form part of the illicium family, e.g. Merrilactone A (1),[2] 
Anislactone A/B (2),[3] and Jiadifenolide (3)[4] (Figure 1a), these 
compounds have received remarkable attention from the 
synthetic community,[5] not least because of their challenging 
chemical structure and their promising biological activity.[2, 4, 6] The 
polycyclic small molecules are capable of promoting outgrowth in 
neuronal cultures.[7] Therefore, these privileged structures are 
considered to hold potential for the development of 
pharmaceuticals for the treatment of neurodegenerative diseases 
such as Parkinson’s or Alzheimer’s (AD).[8] In contrast to protein 
neurotrophins,[9] e.g. nerve growth factor (NGF) or brain-derived 
neurotrophic factor (BNDF), small-molecule neurotrophin-like 
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compounds have been investigated because of their desirable 
pharmacokinetic properties and pharmacological advantages, i.e. 
low molecular weight, high serum stability and most importantly 
blood-brain-barrier permeability.[10] In the case of majucin-type 
sesquiterpenes, such as Jiadifenolide (2), several studies were 
conducted in order to determine a common pharmacophoric 
motif.[6a, c] These investigations led to the identification of several 
potent analogs and therefore have shown that certain synthetic 
derivatives can have activities comparable to the natural product. 
 
Although a great number of synthetic studies on 
Merrilactone A (1) and Anislactone A/B (2) have been performed, 
no systematic investigation on their structure-activity relationship 
is available. This might be due to the length of the syntheses 
reported. As a consequence, variations of the carbon frameworks 
of the natural products are not readily accessible. We realized that 
in order to overcome this limitation a synthetic route, which 
provides simple access to the core structure, was required. An 
efficient synthesis of the carbon framework would then allow for 
versatile modification and preparation of natural product 
derivatives.  
Results and Discussion 
We focused our studies on the structural core motif (see figure 1a, 
marked in grey), which consists of a highly substituted central ring 
structure surrounded by additional rings including a cyclopentane 
and a -lactone. Specifically, our aim was to synthesize structural 
simplified analogs, investigate their neurite outgrowth activity and 
ultimately learn about the structure-activity relationship. 
Importantly, we have placed the emphasis on synthesizing 
simplified analogs, i.e. carbon framework derivatives of ()-1 and 
()-2. Two rationally simplified structural derivatives 4 and 5 
(Figure 1b) were designed by altering the oxidation state and by 
targeted disconnection of hydroxo functionalities, e.g. oxetane 
and lactone moieties. The synthetic strategy towards these two 
derivatives is based on the rapid construction of the polycyclic 
structure from readily available enones. Retrosynthetically, 
structure 4 (Figure 1b) can be traced back to cyclopentenone 7 
via ring disconnection to diketone 6. Analogously, lactone 5 is 
constructed from bicyclic ketone 9. Here, the -lactone ring is 
attached by employing the pre-functionalized enone 8.  
Synthesis of the core structure (depicted in Scheme 1) starts with 
commercially available dimethylcyclopentenone (10) which was 
subjected to an-methoxycarbonylation using Mander’s 
reagent,[11] followed by methylation of the 1,3-dicarbonyl with 
methyl iodide. A 1,4-addition of the in situ formed cuprate gave 
rise to 12 in excellent yield (96%) and with a diastereoselectivity 
of 2.3:1. The two diastereomers could be separated via column 
chromatography. After Wacker-oxidation, the desired syn-
configuration of diketone 13 was confirmed by X-ray crystal 
structure analysis. Attempts to close the cyclopentene ring failed 
under a variety of basic conditions. However, treatment with p-
toluene sulfonic acid[12] provided bicyclic ketone 14, along with 
conjugated iso-14 (r.r. = 2:1), which could be recycled via acidic 
equilibration. Finally, -alkylation with bromo alkyl acetate yielded 
structures 15 and 16 (R = Et or Me). The route described allows 
for the gram-scale access to diastereomerically pure carbon 
framework derivatives of the natural products.  
Furthermore, we were interested in structure derivatives carrying 
the intact eastern lactone ring. Thus, alcohol 17 was found to be 
a suitable starting point.[13] Functionalization with chloroformate 
and allylic oxidation with chromium(VI) oxide[14] gave enone 18 in 
48% yield over two steps. 1,4-Addition, Wacker-oxidation and 
acidic cyclization provided deconjugated 20 exclusively. Notably, 
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the carbonate group survived these transformations, serving not 
only as a protecting group for the primary alcohol, but also as 
building block and precursor for the lactone moiety, which was 
introduced by treatment with sodium hydride. At this point, the 
diastereomers could be separated via column chromatography 
and the desired syn-configuration of bowl-shaped 21 was 
confirmed by X-ray crystal structure analysis. The 1,3-dicarbonyl 
compound allowed for two selective -alkylations, first with 
potassium carbonate and methyl iodide and then using LDA and 
bromo ethyl acetate. The concise route provided access to the 
complete carbon framework structure 22, which resembles the 
()-Merrilactone A core structure including the eastern lactone 
ring. 
 
With the carbon framework in hand, we turned our attention to 
further modifications of the core structure (see Scheme 2). 
Saponification of diester 16 under standard conditions (KOH in 
aqueous media) allowed for selective hydrolysis of the sterically 
more accessible ester to yield monoacid 23. However, the second 
ester group proved to be unreactive even under forcing conditions, 
presumably because of the steric bulk of the quaternary carbon 
center in -position. Furthermore, in case of successful formation 
of the -keto acid, isolation of the product was thwarted by 
spontaneous decarboxylation. Ultimately, diacid 24 was 
accessible by employing potassium trimethylsilanolate and 
subsequent facile hydrolysis of the silyl ester.[15] For the 
investigation of the core structure at different oxidation levels, we 
turned our attention to reductive modifications of the framework. 
Unfortunately, a selective reduction of the carbonyl functionalities 
proved to be challenging. Only mixtures of different oxidation 
states or decomposed material were obtained with a variety of 
reagents (including borohydrides, aluminum hydrides or 
Bouveault-Blanc conditions[16]). However, triol 25 was accessible 
by employing lithium aluminum hydride reduction with careful 
choice of the work-up method. The configuration of the secondary 
alcohol, pointing outside of the bowl shape structure, was 
unambiguously confirmed by X-ray crystal structure analysis.  
Scheme 2. Synthetic pathways starting from diester 16 to different derivatives 
of the natural product framework. a KOTMS (THF) r.t., 4–6 d, 85–95%; b KOH, 
H2O (MeOH) 70°C, 2 h, 90%; c LAH, (THF) –78 C → r.t., 18 h, 73%; d DMDO, 
(ac) r.t., 2 h, quant.; e TFDO (TFac) –20 °C, 17 h, 64% (1:1). KOTMS = 
potassium trimethylsilanolate, DMDO = dimethyldioxirane, TFDO = 
trifluoromethyl(methyl)dioxirane; TFac = 1,1,1-trifluoroacetone. 
Apparently, direction of the hydride by the primary -alcohol group 
or preorganization by the hydrogen bonding (visible in the 
product’s solid state structure) must have allowed for the hydride 
attack from the sterically more hindered concave side. In order to 
further vary the functionality of the olefin containing ring, we 
examined the epoxidation of ester 16 with TFDO. Surprisingly, the 
reaction yielded not the epoxide, but a mixture of lactones 26 and 
27. These Anislactone-type cyclic structures were presumably 
formed by opening of the epoxide intermediate. The alcohol group 
formed was then further oxidized to the ketone under the reaction 
conditions. Notably, the use of milder DMDO yielded the desired 
epoxide 28, after saponification. 
 
As depicted in Scheme 3, conversion of monoacid 23 with thionyl 
chloride, followed by reaction with aqueous ammonia and 
subsequent epoxidation with m-CPBA yielded amide 29 in 49% 
yield over two steps. X-ray structure analysis confirmed the 
structure and unequivocally proved the convex orientation of the 
epoxide. Carboxylic acid 23 was also exposed to oxidative 
conditions in order to increase the oxidation level of the carbon 
framework. Treatment with copper(II) acetate and hydrogen 
peroxide[17] yielded allylic lactone 30—an unprecedented product 
for these reaction conditions. Even more surprising was the 
formation of oxidation product 31 in the reaction of the epoxidized 
acid with ruthenium(II) chloride and potassium bromate.[18] The 
product was apparently formed by carbon−carbon bond scission 
of the epoxide, subsequent oxidations and acetalization. 
Fortunately, a single crystal suitable for X-ray crystallography was 
obtained, which allowed structure elucidation of the unexpected 
product. 
Scheme 3. Synthesis of epoxy amide 29, and unexpected oxidation products 
30 and 31. a SOCl2, NH3 (CH2Cl2) 50 °C, 2 h, 74%; b mCPBA (CH2Cl2) r.t., 18 h, 
83%; c Cu(OAc)2, H2O2 (MeCN/H2O) r.t. 1.4 h, 40%; d DMDO (ac) r.t., 2 h, 
quant.; e [RuCl3], KBrO3, [py] (MeCN/H2O) 60°C, 17 h, 39% (2 steps). mCPBA 
= meta-chloroperbenzoic acid, DMDO = dimethyldioxirane. 
Additionally, amide derivatives of ester 15 were investigated 
(Scheme 4). After saponification, the amide group[19] was 
introduced by coupling with EDC. Also in this case, the alkene 
could be epoxidized under mild conditions using DMDO. As it 
turned out, synthesis of diamide 32 was surprisingly challenging, 
presumably because of the steric hindrance of the -quaternary 
carbon center. All attempts to convert diacid 24 to the diamide 
failed to give difunctionalized product. However, after having 
tested a variety of conditions, it was found that direct treatment of 
O
CO2Me
EtO2C
H 16
23 (R4 = Me)
24 (R4 = H)
O
CO2Me
H
O
O
O
+
27
O
CO2Me
H
O
O
HO
26
OH
H
OHHO
25 (X-ray)
º
O
CO2R
4
HO2C
H
O
CO2Me
HO2C
H
O
28
a KOH
     or
b KOTMS
b KOH
d DMDO
c LiAlH4
e TFDO
25
O
CO2Me
H
O
O
O
CO2Me
HO2C
H
O
CO2Me
O
H
O
O
HO2C
d DMDO
e [RuCl3], KBrO3,
O
CO2Me
H
O
H2N
O
23
a SOCl2, NH3
b mCPBA
29 (X-ray)
º º
31 (X-ray)
29
30
31
c Cu(OAc)2
   H2O2
49% (2 steps) 39% (2 steps)
40%
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
FULL PAPER    
 
 
 
 
 
the ester 15 with deprotonated amine allowed for conversion of 
both ester groups. By employing trifluoroacetic acid, diamide 32 
could be further transformed to Anislactone-type structure 33, 
which was confirmed by X-ray structure analysis. 
Scheme 4. Synthesis of amide derivatives. R5 = CH2CF3. a n-BuLi, R5-NH2 
(THF) –78°C, 2 h; b TFA (CH2Cl2) r.t., 40 h, 51% (2 steps); c KOH, H2O (MeOH) 
70°C, 2 h; d EDC, R-NH2, [DMAP], NEt3 (CH2Cl2) r.t., 16 h, 29% (2 steps); e 
DMDO, (ac) r.t., 14 h, quant.. TFA = trifluoroacetic acid, EDC = 3-(ethyl-
iminomethyleneamino)-N,N-dimethylpropan-1-amine, DMDO = dimethyl- 
dioxirane. 
In order to investigate the activity profile, we analyzed the effect 
of the prepared compounds on neuronal cells. Previous studies 
have shown that natural products of the illicium family and their 
structural analogs were capable of promoting NGF-mediated 
neurite outgrowth in neuronal cells (rat PC12 cells and primary 
cell cultures).[6c, 20] To explore the scope and species-
independence of the neurotrophic activity of illicium 
sesquiterpenes, we here used mouse N2a cells—an established 
model for neurite outgrowth.[21a-c] We first validated the biological 
activity of a natural illicium sesquiterpene (synthetic Jiadifenolide 
3[5v][22]) in this model and found that it potently enhanced serum 
deprivation-induced neurite outgrowth (140% compared to 
DMSO) with the strongest effect at a concentration of 1000 nM 
(Figure 2 and data not shown). This magnitude of neurite 
outgrowth stimulations is comparable to the effect size of other 
neurotrophic agents in N2a cells[21a-c] as well as the effect of 
Jiadifenolide in other neurotrophic assays.[6c, 20] It is noteworthy 
that N2a cells are not responsive to classical neurotrophins such 
as BDNF, suggesting that the neurotrophic effect of Jiadifenolide 
is independent of these mechanisms. 
Since our synthetic approach has provided access to a variety of 
framework analogs, we next explored the biological profile of the 
synthetic derivatives. Figure 2 shows a graphical representation 
of the results of the biological activity study with the relative 
neurite outgrowth of the N2a cells in comparison to the control run 
(DMSO). An overview of the selected compounds and their 
activities is given in Table 1. 
Figure 3 depicts representative images of selected N2a cells after 
neurite outgrowth in the presence of selected compounds. The 
prolonged dendrites are visible in case of neurotrophically active 
compounds (Figure 3b,c,d) relative to the control (Figure 3a, 
DMSO). Several compounds such as 15, 23 and 30 were 
identified that were almost as potent as (–)-Jiadifenolide, while 
being structurally highly simplified. A SAR analysis suggests that 
structural variations at the northern carboxy group are tolerated 
(methyl ester 15 or acid 23), while modifications of the western 
olefin reduce (compounds 27 and 31) or abolish activity 
(compounds 26 and 28). Likewise, derivatization of the eastern 
ester moiety abrogated activity (compare 2324 and 1622). 
 
Figure 2. Relative neurite outgrowth of N2a-cells with selected compounds (at 
1000 nM concentration) in comparison to control (C, DMSO). Jia = 3, 
(–)-Jiadifenolide, concentration: 1000 nM. Data represent averages of three 
independent runs (analysis of >25 cells for each run). Error bars indicate ± s.e.m. 
***P ≤ 0.001, **P ≤ 0.01, *P < 0.05, ns = not significant. 
The inactivity of 22 was surprising since this eastern lactone motif 
(ring A in Figure 1) is present in Merrilactone A and bioactive 
Jiadifenolide analogs.[6c] Furthermore, the distinct neurite 
outgrowth by lactone 30 (138%) is remarkable, considering that 
Table 1. Overview of carbon framework derivatives and neurite outgrowth. 
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Figure 3. Representative images of N2a-cells after cell differentiation and 
neurite outgrowth. a DMSO (control); b (–)-Jiadifenolide (reference); c 
compound 15; d compound 30 (all at 1000 nM concentration). 
the structure shows a high degree of similarity to the Anislactone 
structure, especially in light of the position of the -lactone moiety. 
Although it has been shown that Merrilactone A can be readily 
converted to the related natural product,[5a] to the best of our 
knowledge the biological activity of Anislactone A/B has not yet 
been validated. The results presented confirm that the natural 
product Merrilactone A can be structurally simplified while 
retaining biological activity. The most active derivatives (15, 23, 
30) are accessible in 6–8 synthetic steps with high yields from 
commercial starting materials. This compares favorably to the 17–
26 steps required for the total syntheses of ()-Merrilactone A 
reported. 
Conclusions 
In conclusion, a series of structural analogs derived from the 
neurotrophic illicium sesquiterpene natural products 
()-Merrilactone A and ()-Anislactone A/B has been synthesized. 
The concise synthetic route relies on the rapid construction of the 
carbon skeleton and enables the gram-scale preparation of the 
diastereomerically pure framework structure. Therefore, access is 
provided to further modified and functionalized analogs. In total, a 
library of 15 framework derivatives has been prepared, enabling 
the analysis of the structure-activity relationship. Our study 
identifies promising structural derivatives, i.e. simplified natural 
product analogs, which are accessible in only 6–8 synthetic steps 
and still promote neurite outgrowth (138% compared to control). 
These results will aid biochemical studies aimed towards 
elucidating the molecular mechanism and relevant targets 
underlying the neurotrophic activity of the illicium sesquiterpenes 
and analogs thereof. The simplified compounds could also 
facilitate the development of new pharmaceuticals for the 
treatment of neurodegenerative diseases. 
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products ()-Merrilactone A and ()-Anislactone A/B is enabled by an efficient 
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biological activity as shown in neurite outgrowth studies.  
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